VSNL1 and neurodegenerative disease: In this study, we report on the development and validation of a novel, highly sensitive Simoa assay for the analysis of VILIP-1 in CSF and serum as well as the application of said immunoassay in a cohort of a variety of neurodegenerative diseases.